Prognostic benefit of maintaining the hemoglobin level during the acute phase in patients with severely decompensated acute heart failure

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Heart and Vessels

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00380-017-1057-5PMID 28956134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The association between in-hospital hemoglobin changes, cardiovascular events, and mortality in acute decompensated heart failure: Results from the ESCAPE trial.

  2016cited by this paper
• Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).

  2016cited by this paper
• Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction

  2016cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study

  2015cited by this paper
• Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†

  2014cited by this paper
• Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).

  2014cited by this paper
• Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).

  2014cited by this paper
• Cardiorenal syndrome.

  2014cited by this paper
• Clinical outcomes of erythropoietin use in heart failure patients with anemia of chronic kidney disease.

  2014cited by this paper
• Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry.

  2013cited by this paper
• Prognostic impact of acute kidney injury in patients with acute decompensated heart failure.

  2013cited by this paper
• Long-term prognostic impact after acute kidney injury in patients with acute heart failure.

  2012cited by this paper
• Anemia in Cardio-Renal Syndrome: clinical impact and pathophysiologic mechanisms

  2011cited by this paper
• Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials.

  2011cited by this paper
• Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006).

  2011cited by this paper
• Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population

  2010cited by this paper
• Anemia: the point of convergence or divergence for kidney disease and heart failure?

  2009cited by this paper
• Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry.

  2009cited by this paper
• The prevalence, nature, and importance of hematologic abnormalities in heart failure.

  2006cited by this paper
• Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options

  2006cited by this paper
• The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

  2006cited by this paper
• Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure: Results From Val-HeFT

  2005cited by this paper
• Are hematinic deficiencies the cause of anemia in chronic heart failure?

  2004cited by this paper
• Anemia as a risk factor and therapeutic target in heart failure.

  2004cited by this paper
• Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).

  2003cited by this paper
• The prognostic importance of anemia in patients with heart failure.

  2003cited by this paper
• Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure

  2003cited by this paper
• Hemodilution Is Common in Patients With Advanced Heart Failure

  2003cited by this paper
• Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.

  2003cited by this paper
• Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.

  2002cited by this paper
• Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study.

  2002cited by this paper
• The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

  2001cited by this paper

• Clinical value of the HATCH score for predicting adverse outcomes in patients with heart failure

  2022cites this paper
• Prognostic Value of Both Plasma Volume Status and Nutritional Status in Patients With Severely Decompensated Acute Heart Failure

  2019influential citation
• Decreased blood glucose at admission has a prognostic impact in patients with severely decompensated acute heart failure complicated with diabetes mellitus

  2018cites this paper